{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:52:33Z","timestamp":1761850353319,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/pat.0b013e328359d505","type":"journal-article","created":{"date-parts":[[2012,10,20]],"date-time":"2012-10-20T06:52:18Z","timestamp":1350715938000},"page":"638-641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical utility of ADAMTS-13 testing in suspected thrombotic microangiopathy: an audit of ADAMTS-13 activity assay requests in routine practice from a tertiary hospital"],"prefix":"10.1016","volume":"44","author":[{"given":"Dominique G.","family":"Garizio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urs","family":"Wilgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwyn A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen A.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/PAT.0b013e328359d505_bib0005","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1055\/s-0037-1614062","article-title":"Thrombotic thrombocytopenic purpura: a paradigm shift?","volume":"84","author":"Cines","year":"2000","journal-title":"J Thromb Haemost"},{"key":"10.1097\/PAT.0b013e328359d505_bib0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Eng J Med"},{"key":"10.1097\/PAT.0b013e328359d505_bib0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1365-2141.2000.01941.x","article-title":"Management of thrombotic thrombocytopenic purpura","volume":"109","author":"Rock","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1097\/PAT.0b013e328359d505_bib0020","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","article-title":"How I treat patients with thrombotic thrombocytopenic purpura: 2010","volume":"116","author":"George","year":"2010","journal-title":"Blood"},{"key":"10.1097\/PAT.0b013e328359d505_bib0025","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Eng J Med"},{"key":"10.1097\/PAT.0b013e328359d505_bib0030","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"Von Willebrand factor cleaving protease in thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome","volume":"26","author":"Furlan","year":"1998","journal-title":"N Eng J Med"},{"key":"10.1097\/PAT.0b013e328359d505_bib0035","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"10.1097\/PAT.0b013e328359d505_bib0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1055\/s-0030-1248727","article-title":"Methodologies and clinical utility of ADAMTS-13 activity testing","volume":"36","author":"Just","year":"2010","journal-title":"Semin Thromb Haemost"},{"key":"10.1097\/PAT.0b013e328359d505_bib0045","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V98.6.1765","article-title":"Specific von Willebrand factorcleaving protease in thrombotic microangiopathies: A study of 111 cases","volume":"89","author":"Veyradier","year":"2001","journal-title":"Blood"},{"key":"10.1097\/PAT.0b013e328359d505_bib0050","first-page":"12735","article-title":"Advantages and limits of ADAMTS-13 testing in thrombotic thrombocytopenic purpura","volume":"6","author":"Franchini","year":"2008","journal-title":"Blood Transfusion"},{"key":"10.1097\/PAT.0b013e328359d505_bib0055","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2141.2008.07276.x","article-title":"Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features","volume":"142","author":"Scully","year":"2008","journal-title":"Br J Haem"},{"key":"10.1097\/PAT.0b013e328359d505_bib0060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/asheducation-2006.1.415","article-title":"Thrombotic thrombocytopenic purpura: a moving target","author":"Sadler","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1097\/PAT.0b013e328359d505_bib0065","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"Kremer Hovinga","year":"2010","journal-title":"Blood"},{"key":"10.1097\/PAT.0b013e328359d505_bib0070","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1538-7836.2010.03761.x","article-title":"ADAMTS-13 assays in thrombotic thrombocytopenic purpura","volume":"8","author":"Peyvandi","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1097\/PAT.0b013e328359d505_bib0075","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1538-7836.2008.03099.x","article-title":"Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13)","volume":"6","author":"Tripodi","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1097\/PAT.0b013e328359d505_bib0080","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/j.1537-2995.2007.01346.x","article-title":"ADAMTS-13 activity and the presence of acquired inhibitors in human immunodeficiency virus-related thrombotic thrombocytopenic purpura","volume":"47","author":"Gunther","year":"2007","journal-title":"Transfusion"},{"key":"10.1097\/PAT.0b013e328359d505_bib0085","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/j.1537-2995.2009.02217.x","article-title":"Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria","volume":"49","author":"Kennedy","year":"2009","journal-title":"Transfusion"},{"key":"10.1097\/PAT.0b013e328359d505_bib0090","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/j.1538-7836.2006.01959.x","article-title":"Human endothelial cells synthesize and release ADAMTS13","volume":"4","author":"Turner","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1097\/PAT.0b013e328359d505_bib0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-0031-1300950","article-title":"Generation and breakdown of soluble ultralarge von Willebrand factor multimers","volume":"38","author":"Turner","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1097\/PAT.0b013e328359d505_bib0100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS-VWF73, a first fluorogenic substrate for ADAMTS-13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1097\/PAT.0b013e328359d505_bib0105","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/blood-2003-11-4035","article-title":"Effect of plasma exchange on plasma ADAMTS-13 metalloprotease activity, inhibitor level and clinical outcome in patients with idiopathic and non-idiopathic thrombotic thrombocytopenic purpura","volume":"103","author":"Zheng","year":"2004","journal-title":"Blood"},{"key":"10.1097\/PAT.0b013e328359d505_bib0110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12185-009-0481-4","article-title":"Pivotal role of ADAMTS-13 in liver diseases","volume":"91","author":"Uemura","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1097\/PAT.0b013e328359d505_bib0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1055\/s-0032-1306431","article-title":"Autoimmune thrombocytopenic microangiopathy: advances in pathogenesis, diagnosis and management","volume":"38","author":"Tsai","year":"2012","journal-title":"Semin Thromb Hemost"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516324540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516324540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:15:45Z","timestamp":1758471345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516324540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0031302516324540"],"URL":"https:\/\/doi.org\/10.1097\/pat.0b013e328359d505","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utility of ADAMTS-13 testing in suspected thrombotic microangiopathy: an audit of ADAMTS-13 activity assay requests in routine practice from a tertiary hospital","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/PAT.0b013e328359d505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}